Quantitative estimation of attenuation in ultrasound video images: Correlation with histology in diffuse liver disease

Investigative Radiology

Volumn 35, Issue 5, 2000, Pages 319-324

  Graif, Moshe ^a   Yanuka, Moti ^b,c   Baraz, Mimi ^a   Blank, Anat ^a   Moshkovitz, Menachem ^a   Kessler, Ada ^a   Gilat, Tuvia ^a   Weiss, Judith ^a   Walach, Eugene ^d   Amazeen, Paul ^b,c   Irving, Charles S ^b,c  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c Frantz Medical Development   (United States)

^d IBM HAIFA RESEARCH LAB   (Israel)

Author keywords

Acoustic attenuation; Diffuse liver disease; Steatosis; Ultrasound

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; ECHOGRAPHY; HISTOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LIVER DISEASE; PRIORITY JOURNAL; RADIATION ATTENUATION; SCHOOL CHILD; STEATOSIS;

EID: 12944284724     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-200005000-00006     Document Type: Article

References (27)

1. Sanford NL, Welsh P, Matis C, Baddely H, Powell LW. Is ultrasonography useful in the assessment of diffuse parenchymal liver disease? Gastroenterology 1985;89:186-191
2. Needelman L, Kurtz AB, Rifkin MD, Cooper HS, Pasto ME, Goldberg BB. Sonography of diffuse benign liver disease: Accuracy pattern recognition and grading. AJR 1986;146:1011-1015.
3. Badawi AM, Derbala AS, Youssef AM. Fuzzy logic algorithm for quantitative tissue characterization of diffuse liver diseases from ultrasound images. Int J Med Inf 1999;55:135-147.
4. Lu ZF, Zagzebski JA, O'Brien RT, Steinberg H. Ultrasound attenuation and backscatter in the liver during prednisone administration. Ultrasound Med Biol 1997;23:1-8.
5. Lu ZF, Zagzebski JA, Lee FT. Ultrasound backscatter and attenuation in human liver with diffuse disease. Ultrasound Med Biol 1999;25: 1047-1054.
6. Nicoll RG, Jackson MW, Knipp BS, Zagzebski JA, Steinberg H, O'Brien RT. Quantitative ultrasonography of the liver in cats during obesity induction and dietary restriction. Res Vet Sci 1998;64: 1-6.
7. O'Brien RT, Zagzebski JA, Lu ZF, Steinberg H. Measurement of acoustic backscatter and attenuation in the liver of dogs with experimentally induced steroid hepatopathy. Am J Vet Res 1996; 57:1690-1694.
8. Syakalima M, Takiguchi M, Yasuda J, Morita Y, Hashimoto A. Comparison of attenuation and liver-kidney contrast of liver ultrasonographs with histology and biochemistry in dogs with experimentally induced steroid hepatopathy. Vet Q 1998;20:18-22.
9. Zimmerman KF, Smith JC. Ultrasound velocity in fixed human liver: Empirical ANOVA and regression modeling on histologically assessed abnormalities. Ultrason Imaging 1983;5:280-294.
10. O'Donnell M, Reilly HB. Clinical evaluation of the B-scan. IEEE Trans Sonics Ultrasonics 1985;32(suppl):450-456.
11. Krasner BH, Garra BS, Mun SK. US tissue characterization workstation: Applications and design. Radiographics 1994;14:1415-1422.
12. Rail RW, Johnson MB, Kanel G, et al. FM sonography in diffuse liver disease: Prospective assessment and blinded analysis. Radiology 1986;161:451-454.
13. Hoefs JC, Aufrichtig D, Lottenberg S, et al. A non invasive evaluation of hepatic fibrosis using frequency demodulation of ultrasound signals. Dig Dis Sci 1986;31:1045-1046.
14. Kuc R. Clinical application of the ultrasound attenuation estimation technique for liver pathology characterization. IEEE Trans Biol Med Eng 1980;27:312-318.
15. Bamber JC, Hill CR, King JA. Acoustic properties of normal and cancerous human liver. Ultrasound Med Biol 1981;7:135-141.
16. Narayama PA, Ophir J, Bal V. On the dependence of attenuation in normal and fatty liver. IEEE Trans Sonic Ultrason 1983;36(suppl): 379-383.
17. Maklad MF, Ophir J, Bal V. Attenuation of ultrasound in normal and diffuse liver disease in vivo. Ultrason Imag 1984;6:117-125.
18. Wilson LS, Robinson DE, Doust BD. Frequency domain processing for ultrasonic attenuation measurement in liver. Ultrason Imag 1984;6:278-292.
19. King DL, Lizzi FL, Felppa FJ, et al. Focal diffuse liver disease studied by quantitative microstructural sonography. Radiology 1985;155: 457-462.
20. Ophir J, Shawker TH, Maklad NF, et al. Attenuation estimation in reflection: Progress and prospects. Ultrason Imag 1984;6:349-395.
21. Garra BS, Shawker TH, Nassi M, Russell MA. Ultrasound attenuation measurements of the liver in vivo using commercial sector scanner. Ultrason Imag 1984;6:396-407.
22. Parker KJ, Asztely MS, Lerner RN, Schenk EA, Waag RC. Frequency dependent attenuation in normals and diseased livers. IEEE Ultrasound Symposium 1986:1-3.
23. Cloostermans MJTM, Mol H, Verhoef WM, Thijssen, Kubat JM. In vitro estimation of acoustic parameter of the liver and correlation with histology. Ultrasound Med Biol 1986;12:39-51.
24. Garra BS, Insana MF, Shawker TH, Russell MA. Quantitative estimation of liver attenuation and echogenicity: Normal state versus diffuse liver disease. Radiology 1987;162:61-67.
25. Wilson LS, Robinson DE, Griffiths KA, Manhoharan A, Doust BD. Evaluation of ultrasonic attenuation in diffuse diseases of spleen and liver. Ultrason Imag 1987;9:236-247.
26. Duerinckx AJ, Rosenberg K, Hoefs J, et al. In vivo acoustic attenuation in liver: Correlation with blood tests and histology. Ultrasound Med Biol 1988;14:405-413.
27. Taylor KJW, Riely CA, Hammers L, et al. Quantitative US attenuation in normal liver and in patients with diffuse liver disease: Importance of fat. Radiology 1986;160:65-71.